SAENGDAO PHONXAYLINKHAM: Open Payments
NPI 1083253975 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,117 in 17 payments from 14 companies in 2025. Trend: 2023 $1,689 · 2024 $2,696 · 2025 $2,117
Food & beverage: $2,117
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $283 |
| Novo Nordisk Inc | 2 | $250 |
| ABBVIE INC. | 2 | $250 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| Exact Sciences Corporation | 1 | $122 |
| Dexcom, Inc. | 1 | $122 |
Products named: ONPATTRO, REZDIFFRA, ZORYVE, Leqembi, Wegovy, VRAYLAR, VYVGART, Ozempic.
Industry payments across CA — which companies pay providers there.
